About Quidel Corporation
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company's diagnostic testing solutions primarily include applications in infectious diseases, women's health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers. It markets its products in the United States through a network of national and regional distributors and a direct sales force. Internationally, it sells and markets primarily through distributor arrangements. Its diagnostic solutions are used in the detection and diagnosis of many critical diseases and other medical conditions, including autoimmune diseases, bone health and thyroid diseases. It provides diagnostic testing solutions under various brand names, including Quidel, QuickVue+ and Thyretain.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Diagnostic Substances
- Sub-Industry: Health Care Supplies
- Exchange: NASDAQ
- Symbol: QDEL
- CUSIP: 74838J10
- Previous Close: $21.41
- 50 Day Moving Average: $19.93
- 200 Day Moving Average: $21.15
- 52-Week Range: $15.08 - $23.94
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 54.23
- P/E Growth: 6.59
- Market Cap: $696.89M
- Outstanding Shares: 32,643,000
- Beta: 1.27
- Net Margins: -7.21%
- Return on Equity: -0.50%
- Return on Assets: -0.26%
Companies Related to Quidel Corporation:
- Debt-to-Equity Ratio: 0.74%
- Current Ratio: 8.23%
- Quick Ratio: 7.31%
What is Quidel Corporation's stock symbol?
Quidel Corporation trades on the NASDAQ under the ticker symbol "QDEL."
Where is Quidel Corporation's stock going? Where will Quidel Corporation's stock price be in 2017?
4 brokerages have issued 1 year price objectives for Quidel Corporation's shares. Their forecasts range from $21.50 to $22.00. On average, they expect Quidel Corporation's stock price to reach $21.83 in the next twelve months.
When will Quidel Corporation announce their earnings?
Quidel Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, April, 25th 2017.
Who owns Quidel Corporation stock?
Quidel Corporation's stock is owned by many different of retail and institutional investors. Top institutional investors include Brown Capital Management LLC (17.58%), Janus Capital Management LLC (6.35%), Arrowpoint Asset Management LLC (3.96%), Dimensional Fund Advisors LP (2.62%), Gabelli Funds LLC (2.08%) and Gamco Investors INC. ET AL (1.92%). Company insiders that own Quidel Corporation stock include Douglas C Bryant, John Tamerius and Robert Joseph Bujarski.
Who sold Quidel Corporation stock? Who is selling Quidel Corporation stock?
Quidel Corporation's stock was sold by a variety of institutional investors in the last quarter, including Janus Capital Management LLC, Dimensional Fund Advisors LP, Menta Capital LLC, Baird Financial Group Inc., Brown Capital Management LLC, First Light Asset Management LLC, Two Sigma Investments LP and Wall Street Associates. Company insiders that have sold Quidel Corporation stock in the last year include Douglas C Bryant, John Tamerius and Robert Joseph Bujarski.
Who bought Quidel Corporation stock? Who is buying Quidel Corporation stock?
Quidel Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Arrowpoint Asset Management LLC, Arrowstreet Capital Limited Partnership, State Street Corp, Renaissance Technologies LLC and Fred Alger Management Inc..
How do I buy Quidel Corporation stock?
Shares of Quidel Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Quidel Corporation stock cost?
One share of Quidel Corporation stock can currently be purchased for approximately $21.15.